Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer

MLA

Niraj Babu, et al. “Phosphoproteomic Analysis Identifies CLK1 as a Novel Therapeutic Target in Gastric Cancer.” Gastric Cancer, vol. 23, Apr. 2020, pp. 796–810. EBSCOhost, https://doi.org/10.1007/s10120-020-01062-8.

APA

Niraj Babu, Pavithra Rajagopalan, Saravanan Thiyagarajan, Sanjay Navani, Rekha V. Kumar, Sonali V. Mohan, Gajanan Sathe, Sneha M. Pinto, Oliyarasi Muthusamy, Tejaswini Subbannayya, Jayshree Advani, Gopal Gopisetty, Manoj Rajappa, Akhilesh Pandey, Vinod D. Radhakrishna, Pradip K. Majumder, Aditi Chatterjee, Thangarajan Rajkumar, Padhma Radhakrishnan, … Manjusha Biswas. (2020). Phosphoproteomic analysis identifies CLK1 as a novel therapeutic target in gastric cancer. Gastric Cancer, 23, 796–810. https://doi.org/10.1007/s10120-020-01062-8

Chicago

Niraj Babu, Pavithra Rajagopalan, Saravanan Thiyagarajan, Sanjay Navani, Rekha V. Kumar, Sonali V. Mohan, Gajanan Sathe, et al. 2020. “Phosphoproteomic Analysis Identifies CLK1 as a Novel Therapeutic Target in Gastric Cancer.” Gastric Cancer 23 (April): 796–810. doi:10.1007/s10120-020-01062-8.